查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080356

家庭檢測與居家醫療市場：2026-2032年全球市場預測（按服務類型、檢體類型、檢測方法、年齡層、應用、最終用戶和分銷管道分類）

Home Testing & Home Healthcare Market by Offering, Sample Type, Testing Modality, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，家庭檢測和居家醫療市場將成長至 5,693.7 億美元，複合年成長率為 8.60%。

主要市場統計數據
基準年 2025 3194.9億美元
預計年份：2026年 3464.6億美元
預測年份 2032 5693.7億美元
複合年成長率 (%) 8.60%

居家檢測和居家醫療正從以便利性為導向的服務轉向支持預防保健、慢性病管理、急性後期康復以及居家養老模式的核心基礎設施。這項需求是由已顯現的人口結構和疾病趨勢所驅動的。聯合國預測，2021年至2050年間，全球65歲以上人口將成長一倍以上，而世界衛生組織（世衛組織）則將非傳染性疾病列為全球主要死因之一。這些因素推動了對分散式診斷、遠端患者監護、居家護理、藥物管理、復健以及虛擬優先的護理協調的需求。

此外，大規模新冠病毒檢測使消費者對居家診斷更加熟悉，保險公司對遠端保健和遠端監測的接受度不斷提高，以及醫療服務提供者為減少不必要的住院治療所做的努力，都在重塑著醫療行業。對於醫療產業的領導者而言，商機不再局限於銷售居家檢測套組或提供一次性上門服務。競爭優勢越來越依賴整合式醫療服務路徑，該路徑將居家數據、臨床決策支援、檢測網路、數位療法、藥房服務以及安全的病人參與平台連接起來。

居家醫療格局的變革性變化

家庭檢測和居家醫療領域正從以醫療機構為中心的介入模式轉向以病人為中心的去中心化照護模式。醫院和醫療保健系統正在利用居家醫療來控制床位佔用率、減少再入院率並支持患者出院後的康復。同時，診斷測試開發商正在擴大家庭檢測的範圍，包括直接面對消費者的檢測和由醫療保健提供者開立處方箋的檢測，用於呼吸道感染疾病、不孕症、性健康、糖尿病、心血管疾病風險和健康監測等領域。

人工智慧在居家照護的累積影響

人工智慧（AI）不僅僅是一項單一的技術升級；它正在對家庭檢測和居家醫療整體累積的影響。在診斷領域，人工智慧正在輔助進行影像診斷、症狀分流、風險分層以及連網設備的品管。在居家醫療營運中，人工智慧正在利用患者產生的健康數據來改善日程安排、最佳化路線、制定個人化護理計劃、檢測詐欺行為、輔助文件記錄以及發出早期預警。

主要區域洞察：亞太地區、北美地區、拉丁美洲地區、歐洲地區、中東和非洲地區

亞太地區是居家檢測和居家醫療發展最快的地區之一。這主要得益於日本、韓國、中國和澳洲人口老化，以及印度和東南亞對數位醫療領域投資的增加。各國政策日益重視基層醫療、遠端醫療、診斷服務取得和老年護理，使得居家檢測和遠端患者監護在成熟和新興的醫療保健體系中都變得日益重要。北美地區憑藉其完善的報銷機制、消費者對居家診斷的廣泛接受、健全的居家醫療基礎設施以及保險公司對遠端監測、慢性病管理和居家醫院模式的關注，仍然保持著高度領先地位。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團與北約

在東南亞國協，各國政府正在擴大基層醫療、電子健康記錄、全民健康覆蓋（UHC）計劃和社區醫療服務，從而催生了對價格合理的居家診斷和遠距醫療的需求。在海灣合作理事會（GCC）國家，居家醫療正作為更廣泛的醫療轉型計劃的一部分被引入，該計劃將高度數位化應對力與對慢性病管理、老年護理、預防性篩檢以及在傳統醫療機構之外提供的高品質臨床服務的需求相結合。

對主要家庭檢測和居家醫療市場關鍵國家的洞察

美國正居家醫療聯邦醫療保險（Medicare）福利、遠端患者監護報銷代碼、FDA監管的診斷設備以及大規模的私人保險公司體系，引領居家醫療的商業化進程。加拿大則專注於公共資助的護理協調、虛擬醫療服務以及居家養老支持，而墨西哥和巴西則在拓展私人診斷服務、居家照護和遠端醫療，以解決醫療保健服務取得方面的不平等問題，並減輕都市區醫療保健系統的負擔。英國正透過國民醫療服務體系（NHS）的虛擬病房舉措和社區護理優先事項來推進居家照護，而德國、法國、義大利和西班牙則在其各自的國家報銷和法定醫療保險體系下，拓展數位醫療、家庭護理和老年護理模式。

為居家檢測和居家醫療。

產業領導者應建構一體化的居家照護生態系統，而非孤立的產品。最有效的策略是將家庭檢體收集、認證實驗室、連網醫療設備、遠距遠端醫療醫生、藥房配藥和家庭護理整合到一個經臨床檢驗的工作流程中。與保險公司、醫院、雇主、社區醫療服務提供者和政府計畫夥伴關係，有助於改善服務可近性、增強信任並為保險報銷做好準備。

調查方法

本執行摘要基於一套系統的調查方法，該方法結合了二手資料研究、監管審查、市場訊號分析和專家解讀。資訊來源包括世界衛生組織（WHO）、經濟合作暨發展組織（OECD）、聯合國機構、美國食品藥物管理局（FDA）、美國醫療保險和醫療補助服務中心（CMS）、歐盟委員會、各國衛生署、同行評審期刊、報銷文件以及來自權威公共衛生資料庫的指南等公開資料和資料。

結論

隨著醫療保健系統致力於實現更早的診斷、更低的醫療成本和更完善的慢性病管理，居家檢測和居家醫療正成為現代醫療保健服務的基礎。人口老化、消費者對遠端醫療以及保險公司將適當的醫療服務從醫院和診所轉移到家庭的意願，都進一步強化了這一行業的長期重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：家庭檢測和居家醫療市場：按服務提供者分類

  • 設備和工具包
    • 監測和診斷設備
      • 血糖值儀
      • 血壓監測儀
      • 體溫計
    • 檢測套組
      • 慢性病檢測
      • 糖尿病檢測
      • 高血壓測試
      • 慢性腎臟病檢測
      • 阿茲海默症檢測
      • 傳染病檢查
    • 治療設備
      • 點滴幫浦
      • 噴霧器
  • 軟體
    • 藥物管理應用程式
    • 遠端監控軟體
    • 遠端醫療平台
    • 健康應用程式
  • 服務
    • 居家護理
    • 孕產婦護理
    • 安寧療護
    • 物理治療

第8章：家庭檢測與居家醫療市場：按樣本類型分類

  • 血
  • 唾液
  • 尿

第9章：居家檢測與居家醫療市場：依檢測方法分類

  • 家庭自測
  • 自行採集樣本並在檢測機構處理
  • 由醫療保健專業人員安排的家庭檢體採集

第10章：家庭檢測與居家醫療市場：依年齡層別分類

  • 兒童
  • 成人
  • 老年人

第11章：家庭檢測與居家醫療市場：按應用領域分類

  • 慢性病管理
  • 不孕症和荷爾蒙分析
  • 健康監測
  • 呼吸監測
  • 心血管疾病監測

第12章：家庭檢測和居家醫療市場：按最終用戶分類

  • 居家照護服務提供者
  • 獨立醫療保健專業人員
  • 個人消費者

第13章：家庭檢測與居家醫療市場：按分銷管道分類

  • 直接面對消費者 (DTC)
  • 線上平台與電子商務
  • 零售藥局和藥房
  • 醫療設備供應商和經銷商

第14章：家庭檢測與居家醫療市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：家庭檢測與居家醫療市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：家庭檢測和居家醫療市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Eurofins Scientific Limited
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company
  • QuidelOrtho Corporation
  • Medline Industries, LP
  • OMRON Healthcare, Inc.
  • Biosynex SA
  • Bionime Corporation
  • ACON Laboratories, Inc.
  • AdvaCare Pharma
  • Alpine Biomedicals Pvt Ltd.
  • Anamol Laboratories Pvt. Ltd.
  • Angstrom Biotech Pvt. Ltd.
  • Atlas Laboratories Ltd
  • Biogenix Inc. Pvt. Ltd.
  • Biolytical Laboratories Inc.
  • i-SENS, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • LifeScan Enterprises LLC
  • Lowenstein Medical SE & Co. KG
  • Nova Biomedical Corporation
  • Precision Biomed
  • SA Scientific Ltd.
  • TaiDoc Technology Corporation
  • Vitalograph Ltd.
  • ZET Biotechnology Co . Ltd.
Product Code: MRR-434CCDA04D32

The Home Testing & Home Healthcare Market is projected to grow by USD 569.37 billion at a CAGR of 8.60% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 319.49 billion
Estimated Year [2026] USD 346.46 billion
Forecast Year [2032] USD 569.37 billion
CAGR (%) 8.60%

Home testing and home healthcare are moving from convenience-led services to core infrastructure for preventive care, chronic disease management, post-acute recovery, and aging-in-place models. Demand is supported by verified demographic and disease trends: the United Nations projects the global population aged 65 years and older to more than double between 2021 and 2050, while the World Health Organization identifies noncommunicable diseases as the leading cause of mortality worldwide. These forces are increasing the need for decentralized diagnostics, remote patient monitoring, home-based nursing, medication management, rehabilitation, and virtual-first care coordination.

The industry is also being shaped by consumer familiarity with at-home diagnostics after large-scale COVID-19 testing, broader payer acceptance of telehealth and remote monitoring, and provider efforts to reduce avoidable hospital utilization. For healthcare leaders, the opportunity is no longer limited to selling home test kits or episodic home visits. Competitive advantage increasingly depends on integrated care pathways that connect home-based data, clinical decision support, laboratory networks, digital therapeutics, pharmacy services, and secure patient engagement platforms.

Transformative Shifts in the Home Healthcare Landscape

The home testing and home healthcare landscape is shifting from facility-centered intervention to distributed, patient-centered care. Hospitals and health systems are using home healthcare to manage bed capacity, reduce readmissions, and support post-discharge recovery, while diagnostic developers are expanding direct-to-consumer and provider-prescribed home testing for respiratory infections, fertility, sexual health, diabetes, cardiovascular risk, and wellness monitoring.

Regulation and reimbursement are also redefining industry priorities. In the United States, FDA oversight of in vitro diagnostics and medical devices, CMS payment pathways for home health and remote patient monitoring, and state licensure rules influence commercialization. In Europe, the EU Medical Device Regulation and In Vitro Diagnostic Regulation strengthen clinical evidence and post-market surveillance expectations. Across emerging economies, public health systems are adopting community-based and home-based care to extend access where clinical workforce and hospital capacity are constrained.

Cumulative Impact of Artificial Intelligence on Home-Based Care

Artificial intelligence is becoming a cumulative force across home testing and home healthcare rather than a single-point technology upgrade. In diagnostics, AI supports image interpretation, symptom triage, risk stratification, and quality control for connected devices. In home healthcare operations, AI improves scheduling, route optimization, care-plan personalization, fraud detection, documentation support, and early-warning alerts using patient-generated health data.

The most valuable AI applications are those aligned with clinical governance, explainability, and validated outcomes. FDA-cleared AI-enabled medical devices, peer-reviewed clinical algorithms, and human-in-the-loop workflows are setting the standard for responsible adoption. However, AI also introduces risks around bias, privacy, cybersecurity, and overreliance on automated recommendations. Market leaders are prioritizing HIPAA- and GDPR-aligned data architectures, model monitoring, and clinician oversight to convert AI into measurable improvements in access, adherence, and care quality.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

Asia-Pacific is one of the fastest-evolving regions for home testing and home healthcare, supported by aging populations in Japan, South Korea, China, and Australia, as well as expanding digital health investment in India and Southeast Asia. National policy attention to primary care, telemedicine, diagnostics access, and eldercare is improving the relevance of home-based testing and remote patient monitoring across both mature and emerging health systems. North America remains highly advanced due to established reimbursement frameworks, broad consumer adoption of home diagnostics, strong home health infrastructure, and payer interest in remote monitoring, chronic care management, and hospital-at-home models.

Latin America is gaining momentum as private providers and public health systems address urban-rural access gaps, with Brazil and Mexico leading adoption opportunities in diagnostics, telehealth, and home-based chronic disease support. Europe benefits from universal healthcare systems, strong patient-safety regulation, and growing demand for aging-in-place services, although reimbursement fragmentation varies by country and affects the pace of deployment. The Middle East is investing in digital health infrastructure, preventive screening, and premium home care, especially across Gulf economies with high chronic disease burdens and active healthcare modernization programs. Africa remains an access-driven region where home-based testing, community health workers, and mobile-enabled care can reduce diagnostic delays and extend services beyond hospital-centered systems.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

ASEAN markets are increasingly relevant as governments expand primary care, digital health records, universal health coverage initiatives, and community-based health services, creating openings for affordable home diagnostics and remote care. GCC countries are adopting home healthcare as part of broader healthcare transformation programs, combining high digital readiness with demand for chronic disease management, elderly care, preventive screening, and premium clinical services delivered outside traditional facilities.

The European Union is defined by rigorous medical device regulation, cross-border standards, and strong public health systems, making clinical evidence generation, data protection, and compliance essential for market entry. BRICS countries represent scale and diversity, with China, India, and Brazil offering large patient populations and expanding diagnostics capacity, while Russia and South Africa present distinct access, reimbursement, and regulatory dynamics. G7 markets remain innovation leaders due to mature reimbursement structures, advanced device regulation, aging demographics, and high healthcare digitization. NATO-aligned countries, particularly in North America and Europe, also emphasize healthcare resilience, supply chain security, cybersecurity, and digital infrastructure protection, which are increasingly important for connected home healthcare models.

Key Country Insights Across Major Home Testing & Home Healthcare Markets

The United States leads in home healthcare commercialization through Medicare home health payment, remote patient monitoring codes, FDA-regulated diagnostics, and a large private payer ecosystem. Canada emphasizes publicly funded care coordination, virtual care access, and aging-in-place support, while Mexico and Brazil are expanding private diagnostics, home care, and telehealth to address uneven access and pressure on urban health systems. The United Kingdom is advancing home-based care through NHS virtual ward initiatives and community care priorities, while Germany, France, Italy, and Spain are scaling digital health, home nursing, and elderly care models under country-specific reimbursement and statutory health insurance systems.

Russia remains influenced by public-sector healthcare priorities, regional access gaps, and centralized health planning. China is expanding home-based chronic disease support as its population ages and as digital health tools become more integrated into care delivery. India combines high demand with cost-sensitive innovation, diagnostics manufacturing capacity, telemedicine adoption, and expanding public health digitization. Japan and South Korea are mature aging societies with strong demand for remote monitoring, home rehabilitation, and long-term care support. Australia benefits from structured aged care reforms, remote care needs across dispersed geographies, and rising adoption of digital health-enabled home services, particularly where home-based care can improve continuity for older adults and rural communities.

Actionable Recommendations for Home Testing & Home Healthcare Leaders

Industry leaders should build integrated home care ecosystems rather than isolated products. The strongest strategies connect at-home sample collection, certified laboratories, connected medical devices, telehealth clinicians, pharmacy fulfillment, and home nursing into clinically validated workflows. Partnerships with payers, hospitals, employers, community providers, and government programs can improve access, strengthen trust, and support reimbursement readiness.

Organizations should prioritize regulatory readiness, cybersecurity, interoperability, and outcomes evidence. Investments in patient education, multilingual support, last-mile logistics, inclusive device design, and caregiver engagement can improve adherence and reduce test errors. Leaders should also use AI selectively in areas with measurable value, such as risk scoring, staffing optimization, clinical documentation, and remote monitoring alerts, while maintaining clear clinical accountability and transparent escalation protocols.

Research Methodology

This executive summary is built on a structured research methodology combining secondary research, regulatory review, market signal analysis, and expert interpretation. Sources considered include public data and guidance from organizations such as the World Health Organization, Organisation for Economic Co-operation and Development, United Nations agencies, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, European Commission resources, national health ministries, peer-reviewed journals, reimbursement documentation, and recognized public health databases.

The analysis evaluates demand drivers, clinical use cases, technology adoption, reimbursement pathways, regional policy conditions, regulatory requirements, and competitive positioning. Insights are validated through triangulation across demographic indicators, disease burden data, medical device and diagnostics frameworks, provider adoption trends, digital health policies, and published healthcare system priorities to ensure practical relevance for strategic decision-making.

Conclusion

Home testing and home healthcare are becoming foundational to modern healthcare delivery as health systems seek earlier diagnosis, lower-cost care settings, and better chronic disease management. The industry's long-term relevance is reinforced by aging populations, consumer acceptance of remote care, advancements in connected diagnostics, and payer interest in shifting appropriate services from hospitals and clinics to the home.

Success will depend on clinical credibility, trusted data governance, scalable logistics, workforce readiness, and reimbursement alignment. Organizations that combine evidence-based home diagnostics, AI-enabled care coordination, compliant home health delivery, and patient-centered engagement will be best positioned to improve access, safety, and outcomes in decentralized healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Home Testing & Home Healthcare Market, by Offering

  • 7.1. Devices & Kits
    • 7.1.1. Monitoring & Diagnostic Devices
      • 7.1.1.1. Blood Glucose Monitors
      • 7.1.1.2. Blood Pressure Monitors
      • 7.1.1.3. Thermometers
    • 7.1.2. Testing Kits
      • 7.1.2.1. Chronic Disease Testing
      • 7.1.2.1.1. Diabetes Testing
      • 7.1.2.1.2. Hypertension Testing
      • 7.1.2.1.3. Chronic Kidney Disease Testing
      • 7.1.2.1.4. Alzheimer's Disease Testing
      • 7.1.2.2. Infectious Disease Testing
    • 7.1.3. Therapeutic Devices
      • 7.1.3.1. Infusion Pumps
      • 7.1.3.2. Nebulizers
  • 7.2. Software
    • 7.2.1. Medication Management Apps
    • 7.2.2. Remote Monitoring Software
    • 7.2.3. Telehealth Platforms
    • 7.2.4. Wellness Apps
  • 7.3. Services
    • 7.3.1. Home Nursing
    • 7.3.2. Maternal Care
    • 7.3.3. Palliative Care
    • 7.3.4. Physical Therapy

8. Home Testing & Home Healthcare Market, by Sample Type

  • 8.1. Blood
  • 8.2. Saliva
  • 8.3. Urine

9. Home Testing & Home Healthcare Market, by Testing Modality

  • 9.1. At-Home Self-Testing
  • 9.2. Self-Collection With Lab Processing
  • 9.3. Clinician-Orchestrated Home Collection

10. Home Testing & Home Healthcare Market, by Age Group

  • 10.1. Pediatric
  • 10.2. Adult
  • 10.3. Elderly

11. Home Testing & Home Healthcare Market, by Application

  • 11.1. Chronic Disease Management
  • 11.2. Fertility & Hormone Analysis
  • 11.3. Health Monitoring
  • 11.4. Respiratory Monitoring
  • 11.5. Cardiovascular Disease Monitoring

12. Home Testing & Home Healthcare Market, by End User

  • 12.1. Home Care Agencies
  • 12.2. Independent Healthcare Professionals
  • 12.3. Individual Consumers

13. Home Testing & Home Healthcare Market, by Distribution Channel

  • 13.1. Direct-to-Consumer (DTC)
  • 13.2. Online Platforms & E-Commerce
  • 13.3. Retail Pharmacies & Drug Stores
  • 13.4. Medical Equipment Suppliers & Distributors

14. Home Testing & Home Healthcare Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Home Testing & Home Healthcare Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Home Testing & Home Healthcare Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. F. Hoffmann-La Roche Ltd.
  • 18.3. Danaher Corporation
  • 18.4. Eurofins Scientific Limited
  • 18.5. Siemens Healthineers AG
  • 18.6. Thermo Fisher Scientific Inc.
  • 18.7. Becton Dickinson and Company
  • 18.8. QuidelOrtho Corporation
  • 18.9. Medline Industries, LP
  • 18.10. OMRON Healthcare, Inc.
  • 18.11. Biosynex SA
  • 18.12. Bionime Corporation
  • 18.13. ACON Laboratories, Inc.
  • 18.14. AdvaCare Pharma
  • 18.15. Alpine Biomedicals Pvt Ltd.
  • 18.16. Anamol Laboratories Pvt. Ltd.
  • 18.17. Angstrom Biotech Pvt. Ltd.
  • 18.18. Atlas Laboratories Ltd
  • 18.19. Biogenix Inc. Pvt. Ltd.
  • 18.20. Biolytical Laboratories Inc.
  • 18.21. i-SENS, Inc.
  • 18.22. J. Mitra & Co. Pvt. Ltd.
  • 18.23. LifeScan Enterprises LLC
  • 18.24. Lowenstein Medical SE & Co. KG
  • 18.25. Nova Biomedical Corporation
  • 18.26. Precision Biomed
  • 18.27. SA Scientific Ltd.
  • 18.28. TaiDoc Technology Corporation
  • 18.29. Vitalograph Ltd.
  • 18.30. ZET Biotechnology Co . Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DEVICES & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DEVICES & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DEVICES & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MONITORING & DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MONITORING & DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MONITORING & DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL THERMOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THERMOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERMOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIABETES TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIABETES TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIABETES TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HYPERTENSION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HYPERTENSION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HYPERTENSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CHRONIC KIDNEY DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CHRONIC KIDNEY DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CHRONIC KIDNEY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALZHEIMER'S DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALZHEIMER'S DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALZHEIMER'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICATION MANAGEMENT APPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICATION MANAGEMENT APPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICATION MANAGEMENT APPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REMOTE MONITORING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REMOTE MONITORING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REMOTE MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TELEHEALTH PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WELLNESS APPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WELLNESS APPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WELLNESS APPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME NURSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME NURSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME NURSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MATERNAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MATERNAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MATERNAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PALLIATIVE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PALLIATIVE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PALLIATIVE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AT-HOME SELF-TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AT-HOME SELF-TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AT-HOME SELF-TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SELF-COLLECTION WITH LAB PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SELF-COLLECTION WITH LAB PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SELF-COLLECTION WITH LAB PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CLINICIAN-ORCHESTRATED HOME COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICIAN-ORCHESTRATED HOME COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CLINICIAN-ORCHESTRATED HOME COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ELDERLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ELDERLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ELDERLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FERTILITY & HORMONE ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FERTILITY & HORMONE ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FERTILITY & HORMONE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEALTH MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEALTH MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEALTH MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIOVASCULAR DISEASE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CARDIOVASCULAR DISEASE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIOVASCULAR DISEASE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOME CARE AGENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOME CARE AGENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOME CARE AGENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL INDEPENDENT HEALTHCARE PROFESSIONALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL INDEPENDENT HEALTHCARE PROFESSIONALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL INDEPENDENT HEALTHCARE PROFESSIONALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIRECT-TO-CONSUMER (DTC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DIRECT-TO-CONSUMER (DTC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIRECT-TO-CONSUMER (DTC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ONLINE PLATFORMS & E-COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONLINE PLATFORMS & E-COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ONLINE PLATFORMS & E-COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL RETAIL PHARMACIES & DRUG STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL RETAIL PHARMACIES & DRUG STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL RETAIL PHARMACIES & DRUG STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL EQUIPMENT SUPPLIERS & DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL EQUIPMENT SUPPLIERS & DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL EQUIPMENT SUPPLIERS & DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 256. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 260. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. GCC HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 301. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 304. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 305. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 307. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 310. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. G7 HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 316. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 318. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 319. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 320. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 321. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 322. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 325. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 326. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. NATO HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. GLOBAL HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY DEVICES & KITS, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY MONITORING & DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY TESTING KITS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY CHRONIC DISEASE TESTING, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES HOME TESTING & HOME HEALTHCARE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018